🇺🇸 FDA
Patent

US 9708296

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

granted A61KA61K31/444A61K31/4545

Quick answer

US patent 9708296 (6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD) held by Takeda Pharmaceutical Company Limited expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/444, A61K31/4545, A61K31/496, A61K31/4985